New obesity and high blood pressure drug enters human safety testing
NCT ID NCT06148272
First seen Nov 01, 2025 · Last updated May 13, 2026 · Updated 21 times
Summary
This early-stage study is testing a new injectable drug called LY3971297 to see if it is safe and how the body processes it. The trial includes healthy volunteers, people with obesity and high blood pressure, and those with reduced kidney function. Researchers will monitor side effects and measure drug levels in the blood over about 2 to 3 months.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERTENSION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CenExel ACT
RECRUITINGAnaheim, California, 92801, United States
Contact Phone: •••-•••-••••
Contact
-
Clinical Pharmacology of Miami
RECRUITINGMiami, Florida, 33172, United States
Contact Phone: •••-•••-••••
Contact
-
Clinical Research Hospital Tokyo
ACTIVE_NOT_RECRUITINGShinjuku-ku, 160-0004, Japan
-
Hakata Clinic
ACTIVE_NOT_RECRUITINGFukuoka, 812-0025, Japan
-
ICON Early Phase Services
RECRUITINGSan Antonio, Texas, 78209, United States
Contact Phone: •••-•••-••••
Contact
-
Lilly Centre for Clinical Pharmacology
RECRUITINGSingapore, 138623, Singapore
Contact Phone: •••-•••-••••
Contact
-
P-One Clinic
ACTIVE_NOT_RECRUITINGHachiōji, 192-0071, Japan
Conditions
Explore the condition pages connected to this study.